Similar articles

• Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.

  Cox DJ, Mikami AY, Cox BS, Coleman MT, Mahmood A, Sood A, Moore M, Burket R, Merkel RL. Cox DJ, et al. Arch Pediatr Adolesc Med. 2008 Aug;162(8):793-4. doi: 10.1001/archpedi.162.8.793. Arch Pediatr Adolesc Med. 2008. PMID: 18678816 No abstract available.
• Cotempla XR-ODT--another long-acting methylphenidate for ADHD.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2017 Nov 6;59(1533):183-185. Med Lett Drugs Ther. 2017. PMID: 29125594 No abstract available.
• Focalin XR for ADHD.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2009 Mar 23;51(1308):22-4. Med Lett Drugs Ther. 2009. PMID: 19305368 No abstract available.
• [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].

  Golubchik P, Sever J, Weizman A. Golubchik P, et al. Harefuah. 2011 Oct;150(10):788-90, 814. Harefuah. 2011. PMID: 22111124 Review. Hebrew.
• Jornay PM -- evening-dosed methylphenidate for ADHD.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Aug 12;61(1578):126-128. Med Lett Drugs Ther. 2019. PMID: 31386648 Review. No abstract available.